万方数据
万方数据
万方数据
万方数据
万方数据
万方数据
万方数据
万方数据
卵巢癌中紫杉醇耐药机制与克服耐药策略的研究进展
作者：李宁， 李楠， 吴令英， Li Ning， Li Nan， Wu Lingying
作者单位：中国协和医科大学,中国医学科学院,肿瘤医院妇瘤科,北京,100021
刊名：
癌症进展
英文刊名：ONCOLOGY PROGRESS
年，卷(期)：2008,6(1)
被引用次数：6次
参考文献(41条)
1.Oakley BR An abundance of tubulins[外文期刊] 2000(12)
2.Sharp DJ;Rogers GC;Scholey JM Microtubule motors in mitosis[外文期刊] 2000
3.Nogales E Structural insights into microtubule function[外文期刊] 2000(0)
4.Downing KH;Nogales E New insights into microtubule structure and function from the atomic model of tubulin[外文期刊] 1998(5)
5.Rao S;Orr GA;Chaudhary AG Characterization of the taxol binding site on the microtubule.2-(m-Azidobenzoyl) taxol photolabels a peptide (amino acids 217-231) of beta-tubulin[外文期刊] 1995(35)
6.Nicoletti MI;Valoti G;Giannakakou P Expression of beta-tubulin isotypes in human ovarian carcinoma xenografts and in a sub-panel of human cancer cell lines from the NCI-Anticancer Drug
Screen:Correlation with sensitivity to microtubule active agents[外文期刊] 2001(09)
7.Kavallaris M;Kuo DY;Burkhart CA Taxol -resistant epithelial ovarian tumors are associated with altered expression of specific beta-tubulin isotypes[外文期刊] 1997(05)
8.Kavallaris M;Burkhart CA;Horwitz SB Antisense oligonucleotides to class Ⅲ beta -tubulin sensitize drug -resistant cells to taxol[外文期刊] 1999(07)
9.Ohishi Y;Oda Y;Basaki Y Expression of betatubulin isotypes in human primary ovarian carcinoma[外文期刊] 2007(03)
10.Seve P;Reiman T;Lai R Class Ⅲ beta-tubulin is a marker of paclitaxel resistance in carcinomas of unknown primary site[外文期刊] 2007(01)
11.Kgu-Ho-Han E;Gehrke L;Tahir SK Modulation of drug resistance by-α tublin in paclitaxel-resistant human lung cancer cell lines[外文期刊] 2000
12.Monzo M;Rosell R;Sanchez JJ Paclitaxel resistance in non-small-cell lung cancer associated with beta-tubulin gene mutations[外文期刊] 1999(06)
13.Orr GA;Verdier-Pinard P;McDaid H Mechanisms of taxol resistance related to microtubules[外文期刊] 2003(47)
14.Poruchynsky MS;Giannakakou P;Ward Y Accompanying protein alterations in malignant cells with a microtubule-polymerizing drug-resistance phenotype and a primary resistance mechanism[外文期刊] 2001(11)
15.Andre F;Hatzis C;Anderson K Microtubuleassociated protein-tau is a bifunctional predictor of endocrine sensitivity and chemotherapy resistance in estrogen receptor-positive breast cancer[外文期刊] 2007(07)
16.Rouzier R;Rajan R;Wagner P Microtubuleassociated protein-tau:A marker of paclitaxel sensitivity
in breast cancer[外文期刊] 2005(23)
17.Wagner P;Wang B;Clark E Microtubule associated protein (MAP) -tau:A novel mediator of paclitaxel sensitivity in vitro and in vivo[外文期刊] 2005(09)
18.Cardone L;de Cristofaro T;Affaitati A A-kinase anchor protein 84/121 are targeted to mitochondria and mitotic spindles by overlapping amino-terminal motifs[外文期刊] 2002(03)
19.Hollenbeck P Cytoskeleton:Microtubules get the signal[外文期刊] 2001(20)
20.Adeyinka A;Nui Y;Cherlet T Activated mitogen-activated protein kinase expression during human breast tumorigenesis and breast cancer progression[外文期刊] 2002
21.Lehnert M;Emerson S;Dalton WA In vitro evaluation of chemosensitizers for clinical reversal of pglycoprotein-associated taxol resistance 1993
22.Litman T;Druley TE;Stein WD From MDR to MXR:New understanding of multidrug resistance
systems,their properties and clinical significance[外文期刊] 2001(07)
23.Fojo AT;Menefee M Microtubule targeting agents:Basic mechanisms of multidrug resistance (MDR)[外文期刊] 2005(z7)
24.Yokoyama Y;Sato S;Fukushi Y Significance of multi-drug-resistant proteins in predicting chemotherapy response and prognosis in epithelial ovarian cancer 1999
25.Scheffer RJ;Broxterman HJ;Scheffer GL Overexpression of a M (r) 110,000 vesicular protein in non-p-glycoprotein-mediated multidrug resistance 1993(07)
26.Doyle LA;Yang W;Abruzzo LV A multidrug resistance transporter from human MCF -7 breast cancer cells[外文期刊] 1998(26)
27.Tew KD Glutathione-associated enzymes in anticancer drug resistance 1994
28.Townsend DM;Tew KD The role of glutathione-S -transferase in anti-cancer drug resistance[外文期刊] 2003(47)
29.Medeiros R;Pereira D;Afonso N Platinum/paclitaxel-based chemotherapy in advanced ovarian carcinoma:Glutathione S-transgerase genetic polymorphisms predictive biomarkers of disease outcome [外文期刊] 2003
30.Sehuyer M;van der Burg ME;Henzen-Logmans SC Reduce expression of BAX is associated with poor prognosis in patients with epithelial ovarian cancer:A multifactorial analysis of TP53,P21,BAX and BCL2[外文期刊] 2001(9)
31.Ferlini C;Raspaglio G;Mozzetti S Bcl2 downregulation is a novel mechanism of paclitaxel resistance[外文期刊] 2003(1)
32.Cassinelli G;Supino R;Perego P A role for loss of p53 function in sensitivity of ovarian carcinoma cells to taxanes[外文期刊] 2001
https://www.doczj.com/doc/366475247.html,varino C;Pilotti S;Oggionni M P53 gene status and response to platinium/paclitaxel-based chemotherapy in advanced ovarian carcinoma[外文期刊] 2000(23)
34.Gifford G;Paul J;Kaye S The acquisition of hMLH1 methylation in plasma DNA after chemotherapy predicts poor survival for ovarian cancer patients[外文期刊] 2000(13)
35.Agarwal R;Kaye SB Ovarian cancer:Strategies for overcoming resistance to chemotherapy[外文期刊]
2003(07)
36.Lee FY;Borzilleri R;Fairchild CR BMS -247550:A novel epithilone analog with a mode of action similar to paclitaxel but possessing superior antitumor efficacy 2001
37.Kamsteeg M;Rrtherford T;Sapi E Phenoxodiol-an isoflaone analog-induces apoptosis in chemoresistant ovarian cancer cells[外文期刊] 2003(17)
38.Kavanagh J;Kudelka A;Garcia A Phase Ⅱ study of TLK286 administred weekly in patients with platinum refractory or resistant advanced ovarian cancer 2003
39.Vasey PA;McMahon L;Paul J Phase Ⅱ trial of capecitabine in recurrent ovarian cancer[外文期刊] 2003
40.Mavroudis D;Efstathiou E;Polyzos A A phase Ⅰ-Ⅱ trial of gefitinib in combination with vinorelbine and oxaliplatin as salvage therapy in women with advanced ovarian cancer 2004
41.Burger RA;Sill M;Monk BJ Phase Ⅱ trial of bevacizumab in persistent or recurrent epithelial ovarian cancer (EOC) or primary peritoneal cancer (PPC):A Gynecologic Oncology Group (GOG) study 2005
本文读者也读过(9条)
1.马雪莲.查晓.张国楠卵巢癌紫杉醇耐药机制的研究进展[期刊论文]-肿瘤预防与治疗2008,21(4)
2.张文晶.董晓琳.李红霞.ZHANG Wen-Jing.DONG Xiao-Lin.LI Hong-Xia紫杉醇对卵巢癌耐药细胞SKOV3/TAX基因表达谱的影响及耐药机制的探讨[期刊论文]-解放军药学学报2009,25(2)
3.马丁卵巢癌多药耐药机制的探讨[期刊论文]-中华妇幼临床医学杂志（电子版）2007,3(4)
4.殷冬梅人卵巢癌紫杉醇耐药机制的研究[学位论文]2005
5.英焕春.张淑兰.姜涛.欧阳玲.吕靖.YING Huan-chun.ZHANG Shu-lan.JIANG Tao.OUYANG Ling.L(U) Jing应用比较基因组杂交技术对卵巢癌耐药机制的研究[期刊论文]-中华医学杂志2007,87(15)
6.李海燕.王常玉.Li Haiyan.Wang Changyu卵巢癌顺铂耐药机制的研究进展[期刊论文]-医学新知杂志
2009,19(5)
7.李琴琴.辛晓燕.孙建伟.LI Qin-qin.XIN Xiao-yan.SUN Jian-wei Survivin在卵巢癌细胞对紫杉醇耐药中的作用分析[期刊论文]-中国妇幼健康研究2009,20(2)
8.冯继良.姚焕玲.吴强.马传侠.FENG Ji-liang.YAO Huan-ling.WU Qiang.MA Chuan-xia耐药基因检测及体外药敏试验在卵巢癌个体化治疗中的价值[期刊论文]-肿瘤研究与临床2008,20(8)
9.卢美松.邓锁.肖兰.梁铭霖.王泽华卵巢癌耐药细胞株的P38MAPK活性与凋亡关系的研究[期刊论文]-哈尔滨医科大学学报2007,41(2)
引证文献(6条)
1.覃烨.孙琳培美曲塞联合顺铂治疗晚期卵巢癌的临床研究[期刊论文]-中国实用医药 2013(9)
2.张彩清.苑喜明.李慧智紫杉醇脂质体联合卡铂治疗中晚期卵巢上皮癌[期刊论文]-基层医学论坛 2010(31)
3.华英英白介素-2联合化疗对中晚期卵巢癌术后CA125的影响[期刊论文]-浙江中西医结合杂志 2008(8)
4.肖秀兰.任统伟中晚期卵巢癌术后两种化疗方式的临床疗效分析[期刊论文]-现代预防医学 2013(6)
5.徐洁.龚玉环中晚期卵巢癌术后化疗临床分析[期刊论文]-当代医学 2012(17)
6.蒋红元.孙红卵巢癌治疗的研究进展[期刊论文]-老年医学与保健 2009(6)
引用本文格式：李宁.李楠.吴令英.Li Ning.Li Nan.Wu Lingying卵巢癌中紫杉醇耐药机制与克服耐药策略的研究进展[期刊论文]-癌症进展 2008(1)